Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 3,313-3,324 of 10,592
Drug study icon
CompletedNCT00602537

Antidepressant Therapy in Treating Bipolar Type II Major Depression

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand whether a therapy or guided support program can give earlier or clearer feedback during care.

In United States
Bipolarity, DepressionDrugA study involving a medication or substance.Over 18 Years
Countries
United States
Sponsor
University of Pennsylvania
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT00585702

Antimanic Drug Use in Pregnancy

This summary needs review. Please check the official study record and contact the research team for details.

In United States
BipolarityOtherFrom 18 Years to 45 Years
Countries
United States
Sponsor
University of Pittsburgh
Condition
Bipolarity
Drug study icon
CompletedNCT00417482

Antipsychotic Discontinuation in Alzheimer's Disease

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaDrugFrom 50 Years to 95 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Schizophrenia
Drug study icon
TerminatedNCT01621737

Antipsychotic Effects of Oxytocin

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaDrugOver 21 Years
Countries
United States
Sponsor
University of California, San Diego
Condition
Schizophrenia
Drug study icon
TerminatedNCT01913327

Antipsychotic Effects on Brain Function in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaDrugFrom 18 Years to 40 Years
Countries
United States
Sponsor
University of California, San Francisco
Condition
Schizophrenia
Drug study icon
CompletedNCT00018668

Antipsychotic Response in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaDrugFrom 21 Years to 70 Years
Countries
United States
Sponsor
US Department of Veterans Affairs
Condition
Schizophrenia
Drug study icon
CompletedNCT00585273

Antipsychotics and Blood Vessel Function

This study exists to understand how smoking support or smoking-related treatment holds up over time after the earliest research stage. Researchers are trying to understand whether smoking support or smoking-related treatment can better support energy, concentration, and everyday functioning.

In United States
Schizophrenia, BipolarityOtherFrom 18 Years to 50 Years
Countries
United States
Sponsor
Jess G. Fiedorowicz
Condition
Schizophrenia, Bipolarity
Drug study icon
CompletedNCT04724447

ANTIVIRAL TREATMENT OF CYTOMEGALOVIRUS IN DEPRESSION

This study is looking at care and outcomes for people with depression. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.

In United States
DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Laureate Institute for Brain Research, Inc.
Condition
Depression
Behavioral study icon
Active Not RecruitingNCT00737399

Anxiety and Depression Levels in Cancer Patients After Self-Application of EFT (Emotional Freedom Techniques)

This observational study is following people with Depression to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

Remote / online
Depression, AnxietyBehavioralFrom 18 Years to 89 Years
Countries
United States
Sponsor
Soul Medicine Institute
Condition
Depression, Anxiety
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.